Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation
Open accessAbstract
Psychedelic therapy shows promise as a novel intervention for a wide range of mental health concerns but its therapeutic action is incompletely understood. In line with acceptance and commitment therapy’s (ACT’s) transdiagnostic model, qualitative research has suggested that reductions in experiential avoidance are an important component of therapeutic outcomes associated with psychedelics. However, limited research has quantitatively explored the association between decreases in experiential avoidance and therapeutic outcomes associated with psychedelics. Therefore, in two prospective studies, using convenience samples of individuals with plans to use a psychedelic, we explored the impact of psychedelic use on experiential avoidance, depression severity, and suicidal ideation, as well as relationships between changes in these outcomes. Participants (Study 1, N=104; Study 2 N=254) completed self-report questionnaires of depression severity, suicidal ideation, and experiential avoidance: 1) before using a psychedelic (in ceremonial and non-ceremonial contexts), as well as 2) 2-weeks and 3) 4-weeks after psychedelic use. Across both studies, repeated measures ANOVAs indicated significant decreases in experiential avoidance, depression severity, and suicidal ideation after psychedelic use. Furthermore, decreases in experiential avoidance were significantly associated with decreases in depression severity and suicidal ideation. These results suggest that psychedelics may lead to significant decreases in experiential avoidance, depression severity, and suicidal ideation. Additionally, these findings imply that reduced experiential avoidance may be a transdiagnostic mechanism mediating treatment success within psychedelic therapy. We conclude that integrating psychedelics with psychotherapeutic interventions that target experiential avoidance (e.g. ACT) may enhance therapeutic outcomes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Two prospective studies used naturalistic volunteer samples with high attrition (>50%), which may have introduced self-selection and sample biases limiting generalizability.
“Second, although two of these studies employed prospective designs, their use of naturalistic, volunteer samples with high rates of attrition (> 50%) may have contributed self-selection and sample biases that limit generalizability (Close et al., 2020; Zeifman et al., 2020).”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Zeifman et al., 2020
The Methods (Study 1 and Study 2, Procedures and Participants; page unavailable) describe prospective studies with volunteer recruitment, and the Discussion (Limitations and Future Research; page unavailable) identifies possible completer/attrition bias. But the reported follow-up nonresponse was 97 of 279 enrollees in Study 1 and 206 of 478 in Study 2—neither exceeds 50%. The claim’s >50% attrition figure is therefore not supported as stated by this paper. (LLM, conf=0.87)
Experimental — accuracy not yet measuredAcross three prospective samples, psychological flexibility increased and covaried over time with clinical outcomes such as depression and suicidality.
“In particular, across three prospective samples, psychological flexibility showed signs of increasing and covarying over time with clinical outcomes including depression and suicidality (Close et al., 2020; Zeifman et al., 2020).”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Zeifman et al., 2020
These therapies are proposed to work by stimulating psychological flexibility, reducing emotional avoidance, and increasing approach-oriented coping.
“It has been proposed that they exert their effects through the stimulation of psychological flexibility processes that decrease emotional avoidance and increase approach-oriented emotional coping (Davis et al., 2020; Kashdan et al., 2020; Zeifman et al., 2020)”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Zeifman et al., 2020
Recent prospective studies indicate psychological flexibility is a key component in outcomes following psychedelic use.
“A few recent studies, including three prospective studies, have suggested that psychological flexibility is a key component in psychedelic-induced outcomes (Close et al., 2020; Davis et al., 2020; Zeifman et al., 2020).”
From Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca (2022) · cites this paper as Zeifman et al., 2020
Reductions in experiential avoidance were significantly associated with decreases in depression and suicidality scores.
“Reductions in experiential avoidance were significantly associated with decreases in depression and suicidality scores [55].”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [55]
Zeifman and colleagues found experiential avoidance to be significantly reduced at 2 and 4 weeks after psychedelic use.
“Through prospective surveys, Zeifman and colleagues [55] found experiential avoidance (the attempt to avoid or ignore negative or unwanted emotions or cognitions [56];) to be significantly reduced at 2 and 4 weeks after psychedelic use.”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D. S., Quinn, K., Sanislow, C., & Wang, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09091379 · Cited by 7,067 · see citing works
Normality Tests for Statistical Analysis: A Guide for Non-Statisticians
Ghasemi, A., & Zahediasl, S. (2012) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.3505 · Cited by 4,368 · see citing works
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950 · see citing works
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541 · see citing works
Mediators and Mechanisms of Change in Psychotherapy Research
Kazdin, A. E. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091432 · Cited by 2,504 · cited 1× · see citing works
“, see Research Domain Criteria (RDoC); (24)], optimize therapeutic outcomes, and choice of treatment for clients, as well as guide treatment development, refinement and delivery (25).”
BackgroundGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 2× · see citing works
“Recent research has indicated that the intensity of “mystical-type” (4, 6, 7, 9, 22) or “peak” experiences engendered by psychedelics (23) is predictive of positive therapeutic outcomes; however, it remains unclear how (i.”
BackgroundMeasuring experiential avoidance: A preliminary test of a working model
Hayes, S. C., Strosahl, K., Wilson, K. G., Bissett, R. T., Pistorello, J., Toarmino, D., Polusny, M. A., Dykstra, T. A., Batten, S. V., Bergan, J., et al. (2004) · The Psychological Record · doi:10.1007/bf03395492 · Cited by 2,140 · see citing works
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works
Acceptance and commitment therapy.
Hayes, S. C., & Lillis, J. (2012) · American Psychological Association eBooks · doi:10.1037/17335-000 · Cited by 1,543 · see citing works
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works
Self-citationPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · see citing works
REBUS and the anarchic brain: Toward a unified model of the brain action of psychedelics
Carhart-Harris, R. L., & Friston, K. J. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017160 · Cited by 1,180 · see citing works
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151 · cited 1× · see citing works
“Recent research has indicated that the intensity of “mystical-type” (4, 6, 7, 9, 22) or “peak” experiences engendered by psychedelics (23) is predictive of positive therapeutic outcomes; however, it remains unclear how (i.”
BackgroundNock, M. K., Hwang, I., Sampson, N. A., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.29 · Cited by 1,125 · see citing works
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970 · see citing works
Self-citationA-Tjak, J. G. L., Davis, M. L., Morina, N., Powers, M. B., Smits, J. A. J., & Emmelkamp, P. M. G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000365764 · Cited by 921 · cited 1× · see citing works
“Experiential avoidance is a primary target of ACT (26), an evidence-based psychotherapeutic intervention for a range of mental health problems [for a metaanalysis, see (96)].”
BackgroundPalhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., Mota-Rolim, S. A., Osório, F. L., Sanches, R., dos Santos, R. G., et al. (2019) · Psychological Medicine · doi:10.1017/s0033291718001356 · Cited by 852 · see citing works
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808 · see citing works
Self-citationSafety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1110 · Cited by 789 · see citing works
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739 · see citing works
Self-citationThe Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
Carhart-Harris, R. L., & Goodwin, G. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.84 · Cited by 706 · see citing works
Self-citationLong-term follow-up of psilocybin-facilitated smoking cessation
Johnson, M. W., Garcia-Romeu, A., & Griffiths, R. R. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2016.1170135 · Cited by 696 · see citing works
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657 · see citing works
Self-citationPrice, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600 · see citing works
Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589 · see citing works
Self-citationCuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., & van Straten, A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.026 · Cited by 586 · see citing works
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Krebs, T. S., & Johansen, P.-Ø. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112439253 · Cited by 583 · see citing works
(2016) · PubMed · Cited by 580 · see citing works
t-tests, non-parametric tests, and large studies—a paradox of statistical practice?
Fagerland, M. W. (2012) · BMC Medical Research Methodology · doi:10.1186/1471-2288-12-78 · Cited by 549 · see citing works
Gámez, W., Chmielewski, M., Kotov, R., Ruggero, C., & Watson, D. (2011) · Psychological Assessment · doi:10.1037/a0023242 · Cited by 524 · see citing works
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506 · cited 1× · see citing works
“Serotonergic psychedelics, a class of pharmacological agents that act as serotonin 2A receptor (5-HT2AR) agonists, including psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT; contained in the brew ayahuasca), are currently receiving attention within psychiatry and mental health as novel interv…”
Backgroundvan Spijker, B. A. J., Batterham, P. J., Calear, A. L., Farrer, L., Christensen, H., Reynolds, J., & Kerkhof, A. J. F. M. (2014) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12084 · Cited by 492 · see citing works
Psilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476 · see citing works
The brief experiential avoidance questionnaire: Development and initial validation
Gámez, W., Chmielewski, M., Kotov, R., Ruggero, C., Suzuki, N., & Watson, D. (2014) · Psychological Assessment · doi:10.1037/a0034473 · Cited by 450 · see citing works
What Does the Acceptance and Action Questionnaire (AAQ-II) Really Measure?
Wolgast, M. (2014) · Behavior Therapy · doi:10.1016/j.beth.2014.07.002 · Cited by 421 · see citing works
Predicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417 · see citing works
Self-citationEmotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119855974 · Cited by 413 · see citing works
Self-citationDavis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375 · see citing works
Price, R. B., Iosifescu, D. V., Murrough, J. W., Chang, L. C., Al Jurdi, R. K., Iqbal, S. Z., Soleimani, L., Charney, D. S., Foulkes, A. L., & Mathew, S. J. (2014) · Depression and Anxiety · doi:10.1002/da.22253 · Cited by 345 · see citing works
Tyndall, I., Waldeck, D., Pancani, L., Whelan, R., Roche, B., & Dawson, D. L. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2018.09.005 · Cited by 303 · see citing works
Cessation and reduction in alcohol consumption and misuse after psychedelic use
Garcia‐Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845793 · Cited by 287 · see citing works
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.027 · Cited by 286 · see citing works
Suicide Rates Among Adolescents and Young Adults in the United States, 2000-2017
Miron, O., Yu, K., Wilf‐Miron, R., & Kohane, I. S. (2019) · JAMA · doi:10.1001/jama.2019.5054 · Cited by 282 · see citing works
Dimensions over categories: a meta-analysis of taxometric research
Haslam, N., McGrath, M. J., Viechtbauer, W., & Kuppens, P. (2020) · Psychological Medicine · doi:10.1017/s003329172000183x · Cited by 281 · see citing works
The use of the psychological flexibility model to support psychedelic assisted therapy
Watts, R., & Luoma, J. B. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.12.004 · Cited by 269 · see citing works
Self-citationThe timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., Henter, I. D., Salvadore, G., & Zarate, C. A. (2010) · Pharmaceuticals · doi:10.3390/ph3010019 · Cited by 263 · see citing works
Psychedelics and connectedness
Carhart-Harris, R. L., Erritzøe, D., Haijen, E. C. H. M., Kaelen, M., & Watts, R. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4701-y · Cited by 262 · see citing works
Self-citationExperiential Avoidance: An Examination of the Construct Validity of the AAQ-II and MEAQ
Rochefort, C., Baldwin, A. S., & Chmielewski, M. (2018) · Behavior Therapy · doi:10.1016/j.beth.2017.08.008 · Cited by 247 · see citing works
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Roseman, L., Demetriou, L., Wall, M. B., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.041 · Cited by 230 · see citing works
Self-citationUthaug, M. V., van Oorsouw, K., Kuypers, K. P. C., van Boxtel, M., Broers, N. J., Mason, N. L., Toennes, S. W., Riba, J., & Ramaekers, J. G. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4988-3 · Cited by 212 · see citing works
Soler, J., Elices, M., Franquesa, A., Barker, S., Friedlander, P., Feilding, A., Pascual, J. C., & Riba, J. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4162-0 · Cited by 209 · see citing works
Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491524 · Cited by 209 · see citing works
Puglisi‐Allegra, S., & Andolina, D. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.052 · Cited by 203 · see citing works
Emotional blunting with antidepressant treatments: A survey among depressed patients
Goodwin, G. M., Price, J., De Bodinat, C., & Laredo, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.048 · Cited by 202 · see citing works
Sampedro, F., de la Fuente Revenga, M., Valle, M., Roberto, N., Domínguez-Clavé, E., Elices, M., Luna, L. E., Crippa, J. A. S., Hallak, J. E. C., de Araujo, D. B., et al. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx036 · Cited by 200 · see citing works
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., Šuláková, A., Jurok, R., Maryška, M., Kuchař, M., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05236-w · Cited by 197 · see citing works
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
Wolff, M., Evens, R., Mertens, L. J., Koslowski, M., Betzler, F., Gründer, G., & Jungaberle, H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00005 · Cited by 195 · see citing works
Self-citationForstmann, M., Yudkin, D. A., Prosser, A. M. B., Heller, S. M., & Crockett, M. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918477117 · Cited by 185 · see citing works
Shallcross, A. J., Troy, A. S., Boland, M., & Mauss, I. B. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.05.025 · Cited by 177 · see citing works
Cuijpers, P., de Beurs, D. P., van Spijker, B. A. J., Berking, M., Andersson, G., & Kerkhof, A. J. F. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.025 · Cited by 176 · see citing works
Was Eysenck right after all? A reassessment of the effects of psychotherapy for adult depression
Cuijpers, P. J., Karyotaki, E., Reijnders, M., & Ebert, D. D. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000057 · Cited by 174 · see citing works
Sloshower, J., Guss, J., Krause, R., Wallace, R. M., Williams, M. T., Reed, S., & Skinta, M. D. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.002 · Cited by 171 · see citing works
Post-SSRI Sexual Dysfunction: A Literature Review
Bala, A., Nguyen, H. M. T., & Hellstrom, W. J. G. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.07.002 · Cited by 167 · see citing works
Garcia‐Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00955 · Cited by 157 · see citing works
Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2018.1545024 · Cited by 142 · see citing works
. Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.
Rush, A. J., Carmody, T. J., Ibrahim, H. M., Trivedi, M. H., Biggs, M. M., Shores-Wilson, K., Crismon, M. L., Toprac, M. G., & Kashner, T. M. (2006) · Psychiatric Services · doi:10.1176/ps.2006.57.6.829 · Cited by 128 · see citing works
Berking, M., Neacsiu, A., Comtois, K. A., & Linehan, M. M. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.04.011 · Cited by 124 · see citing works
Walser, R. D., Garvert, D. W., Karlin, B. E., Trockel, M., Ryu, D. M., & Taylor, C. B. (2015) · Behaviour Research and Therapy · doi:10.1016/j.brat.2015.08.012 · Cited by 122 · see citing works
Lewis, G., Duffy, L., Ades, A., Amos, R., Araya, R., Brabyn, S., Button, K. S., Churchill, R., Derrick, C., Dowrick, C., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30366-9 · Cited by 120 · see citing works
Stroud, J., Freeman, T. P., Leech, R., Hindocha, C., Lawn, W., Nutt, D., Curran, H. V., & Carhart-Harris, R. L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4754-y · Cited by 104 · see citing works
Self-citationSoler, J., Elices, M., Dominguez-Clavé, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., García-Campayo, J., & Riba, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00224 · Cited by 102 · see citing works
Existing and Novel Biological Therapeutics in Suicide Prevention
Griffiths, J. J., Zarate, C. A., & Rasimas, J. J. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.06.012 · Cited by 94 · see citing works
Hengartner, M. P., & Plöderl, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00517 · Cited by 94 · see citing works
Moroz, M., & Dunkley, D. M. (2019) · Behaviour Research and Therapy · doi:10.1016/j.brat.2018.11.006 · Cited by 89 · see citing works
The impact of Ayahuasca on suicidality: results from a randomized controlled trial
Zeifman, R. J., Palhano-Fontes, F., Hallak, J., Arcoverde, E., Maia-Oliveira, J. P., & Araujo, D. B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01325 · Cited by 87 · see citing works
Self-citationDomínguez‐Clavé, E., Soler, J., Pascual, J. C., Elices, M., Franquesa, A., Valle, M., Álvarez, E., & Riba, J. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5085-3 · Cited by 81 · see citing works
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Lyons, T., & Carhart-Harris, R. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01721 · Cited by 77 · see citing works
Self-citationSpinhoven, P., Drost, J., de Rooij, M., van Hemert, A. M., & Penninx, B. W. J. H. (2016) · Cognitive Therapy and Research · doi:10.1007/s10608-015-9747-8 · Cited by 76 · see citing works
Zeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67 · see citing works
Self-citationPrevention of depression: The state of the science at the beginning of the 21st Century
Barrera, A. Z., Torres, L. D., & Muñoz, R. F. (2007) · International Review of Psychiatry · doi:10.1080/09540260701797894 · Cited by 65 · see citing works
Ellis, T. E., & Rufino, K. A. (2016) · Archives of Suicide Research · doi:10.1080/13811118.2015.1093983 · Cited by 60 · see citing works
Walsh, Z., & Thiessen, M. S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1474088 · Cited by 58 · see citing works
Novel treatment options in depression and psychosis
Češková, E., & Šilhán, P. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s157475 · Cited by 56 · see citing works
Characterizing the course of suicidal ideation response to ketamine
Ballard, E. D., Yarrington, J. S., Farmer, C., Richards, E. M., Machado‐Vieira, R., Kadriu, B., Niciu, M. J., Yuan, P., Park, L., & Zarate, C. A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.077 · Cited by 56 · see citing works
Hengartner, M. P., & Plöderl, M. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501215 · Cited by 56 · see citing works
Luoma, J. B., Sabucedo, P., Eriksson, J., Gates, N., & Pilecki, B. C. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.10.003 · Cited by 56 · see citing works
Close, J. B., Hajien, E. C., Watts, R., Roseman, L., & Carhart-Harris, R. L. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2020.01.005 · Cited by 54 · see citing works
Self-citationGenetic and other risk factors for suicidal ideation and the relationship with depression
Dutta, R., Ball, H. A., Siribaddana, S., Sumathipala, A., Samaraweera, S., McGuffin, P., & Hotopf, M. H. (2017) · Psychological Medicine · doi:10.1017/s0033291717000940 · Cited by 45 · see citing works
Psychological Inflexibility Predicts Suicidality Over Time in College Students
Krafft, J., Hicks, E. T., Mack, S. A., & Levin, M. E. (2018) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12533 · Cited by 41 · see citing works
Psychological Flexibility under Fire: Testing the Incremental Validity of Experiential Avoidance
Vaughan-Johnston, T. I., Quickert, R. E., & MacDonald, T. K. (2017) · Personality and Individual Differences · doi:10.1016/j.paid.2016.10.011 · Cited by 39 · see citing works
Näslund, J., Hieronymus, F., Lisinski, A., Nilsson, S., & Eriksson, E. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2017.24 · Cited by 39 · see citing works
Should antidepressants be used in minor depression?
Naber, D., & Bullinger, M. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/dnaber · Cited by 26 · see citing works
Hegerl, U., Allgaier, A., Henkel, V., & Mergl, R. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.015 · Cited by 25 · see citing works
Cost–effectiveness of preventive interventions for depressive disorders: an overview
Mihalopoulos, C., & Vos, T. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.13.5 · Cited by 22 · see citing works
Rufino, K. A., & Ellis, T. E. (2017) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12353 · Cited by 16 · see citing works
Challenging the promotion of antidepressants for nonsevere depression
Braillon, A., Lexchin, J., Noble, J. H., Menkes, D., M'sahli, L., Fierlbeck, K., Blumsohn, A., & Naudet, F. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13010 · Cited by 16 · see citing works
Einige Überlegungen zur Psychodynamik der Ulkuskranken anhand des Giessen-Tests
Overbeck, G. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000286665 · Cited by 3 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [31]Hayes SC Content, context, and the types of psychological acceptance. In: Hayes SC Jacobson NS Follette VM Dougher MJ, editors. Acceptance and change: Content and context in psychotherapy. Reno, Nevada: Context Press (1994). p. 13– 32.
Cited by
Sorted by citations
Increased global integration in the brain after psilocybin therapy for depression
(2022) · doi:10.1038/s41591-022-01744-z · Cited by 445 · see citing works
Self-citationTherapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression
Murphy, R., Kettner, H., Zeifman, R., Giribaldi, B., Kartner, L., Martell, J., Read, T., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788155 · Cited by 250 · see citing works
Self-citationThe Therapeutic Potential of Psilocybin
Lowe, H. I. C., Toyang, N., Steele, B., Valentine, H., Grant, J. F., Ali, A., Ngwa, W., & Gordon, L. (2021) · Molecules · doi:10.3390/molecules26102948 · Cited by 206 · see citing works
Kettner, H., Rosas, F. E., Timmermann, C., Kärtner, L., Carhart-Harris, R. L., & Roseman, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.623985 · Cited by 221 · see citing works
Self-citationWatts, R., Kettner, H., Geerts, D., Gandy, S., Kärtner, L., Mertens, L. J., Timmermann, C., Nour, M. M., Kaelen, M., Nutt, D., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06187-5 · Cited by 169 · see citing works
Self-citationRoss, S., Agin-Liebes, G., Lo, S., Zeifman, R. J., Ghazal, L., Benville, J., Franco Corso, S., Bjerre Real, C., Guss, J., Bossis, A., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00020 · Cited by 139 · see citing works
Self-citationAgin-Liebes, G., Haas, T. F., Lancelotta, R., Uthaug, M. V., Ramaekers, J. G., & Davis, A. K. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00018 · Cited by 124 · see citing works
Psychedelics and psychotherapy: Cognitive-behavioral approaches as default
Yaden, D. B., Earp, D., Graziosi, M., Friedman-Wheeler, D., Luoma, J. B., & Johnson, M. W. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.873279 · Cited by 110 · see citing works
Spriggs, M. J., Kettner, H., & Carhart-Harris, R. L. (2021) · Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity · doi:10.1007/s40519-020-01000-8 · Cited by 105 · see citing works
Self-citationDoes Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Kočárová, R., Horáček, J., & Carhart-Harris, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.661233 · Cited by 96 · see citing works
Self-citationZeifman, R. J., Singhal, N., SANTOS, R. G. D., Sanches, R. F., Osório, F. D. L., Hallak, J. E. C., & Weissman, C. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05692-9 · Cited by 83 · see citing works
Self-citationMcCulloch, D. E.-W., Madsen, M. K., Stenbæk, D. S., Kristiansen, S., Ozenne, B., Jensen, P. S., Knudsen, G. M., & Fisher, P. M. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026454 · Cited by 83 · see citing works
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Payne, J. E., Chambers, R., & Liknaitzky, P. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00034 · Cited by 78 · see citing works
Raison, C. L., Jain, R., Penn, A., Cole, S. P., & Jain, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.831092 · Cited by 79 · see citing works
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works
Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
Spriggs, M. J., Douglass, H. M., Park, R. J., Read, T., Danby, J. L., de Magalhães, F. J. C., Alderton, K. L., Williams, T. M., Blemings, A., Lafrance, A., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.735523 · Cited by 75 · see citing works
Self-citationPsychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works
On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review
Zeifman, R. J., Singhal, N., Breslow, L., & Weissman, C. R. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00024 · Cited by 66 · see citing works
Self-citationMans, K., Kettner, H., Erritzøe, D., Haijen, E. C. H. M., Kaelen, M., & Carhart-Harris, R. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.647909 · Cited by 60 · see citing works
Self-citationZeifman, R. J., Wagner, A. C., Monson, C. M., & Carhart-Harris, R. L. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.105 · Cited by 65 · see citing works
Self-citationPsychiatric risks for worsened mental health after psychedelic use
Marrocu, A., Kettner, H., Weiss, B., Zeifman, R. J., Erritzoe, D., & Carhart-Harris, R. L. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241232548 · Cited by 60 · see citing works
Self-citationSloshower, J., Zeifman, R. J., Guss, J., Krause, R., Safi-Aghdam, H., Pathania, S., Pittman, B., & D’Souza, D. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-58318-x · Cited by 65 · see citing works
“Furthermore, following classic psychedelic use, increases in psychological flexibility have been found to be associated with improvements in mental health, including depressive symptoms 22,36 , anxious/depressive symptoms 21 , positive and negative affect 37 , and grief 38 .”
BackgroundSelf-citationWolff, M., Mertens, L. J., Walter, M., Enge, S., & Evens, R. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211073758 · Cited by 58 · see citing works
Self-citationKopra, E. I., Ferris, J., WINSTOCK, A. R., Kuypers, K. P. C., Young, A. H., & Rucker, J. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231158245 · Cited by 61 · see citing works
Wang, Y., Tian, J., & Yang, Q. (2024) · Psychiatry and Clinical Psychopharmacology · doi:10.5152/pcp.2024.23777 · Cited by 59 · see citing works
Psilocybin for Trauma-Related Disorders
Khan, A. J., Bradley, E., O’Donovan, A., & Woolley, J. (2022) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2022_366 · Cited by 55 · see citing works
Evens, R., Schmidt, M. E., Majić, T., & Schmidt, T. T. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231172254 · Cited by 56 · see citing works
LSD use in the United States: Trends, correlates, and a typology of us
Killion, B., Hai, A. H., Alsolami, A., Vaughn, M. G., Oh, P. S., & Salas‐Wright, C. P. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108715 · Cited by 55 · see citing works
Agin-Liebes, G., Zeifman, R., Luoma, J. B., Garland, E. L., Campbell, W. K., & Weiss, B. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221080165 · Cited by 54 · see citing works
“%) may have contributed self-selection and sample biases that limit generalizability (Close et al., 2020; Zeifman et al., 2020).”
BackgroundResultInfluentialSelf-citationSkosnik, P. D., Sloshower, J., Safi-Aghdam, H., Pathania, S., Syed, S., Pittman, B., & D’Souza, D. C. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231179800 · Cited by 51 · see citing works
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Calder, A. E., Mock, S., Friedli, N., Pasi, P. R., & Hasler, G. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.05.008 · Cited by 48 · see citing works
Breeksema, J. J., Niemeijer, A. R., Kuin, B., Veraart, J. K. E., Kamphuis, J., Schimmel, N., van den Brink, W., Vermetten, E. H. G. J. M., & Schoevers, R. A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.948115 · Cited by 47 · see citing works
Psychedelic-assisted psychotherapy: Where is the psychotherapy research
Aday, J. S., Horton, D., Fernandes-Osterhold, G., O’Donovan, A., Bradley, E. R., Rosen, R. C., & Woolley, J. D. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06620-x · Cited by 54 · see citing works
Counselors’ attitudes toward psychedelics and their use in therapy
Hearn, B., Brubaker, M. D., & Richardson, G. B. (2022) · Journal of Counseling & Development · doi:10.1002/jcad.12429 · Cited by 45 · see citing works
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Zeifman, R. J., Spriggs, M. J., Kettner, H., Lyons, T., Rosas, F. E., Mediano, P. A. M., Erritzøe, D., & Carhart-Harris, R. L. (2025) · Scientific Reports · doi:10.1038/s41598-023-28111-3 · Cited by 54 · see citing works
Self-citationPsilocybin and Other Classic Psychedelics in Depression
Nutt, D., Peill, J. M., Weiss, B., Godfrey, K., Carhart-Harris, R. L., & Erritzøe, D. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_451 · Cited by 37 · see citing works
Self-citationPrevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca
Weiss, B., Wingert, A., Erritzoe, D., & Campbell, W. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-36184-3 · Cited by 33 · see citing works
Weiss, B., Roseman, L., Giribaldi, B., Nutt, D., Carhart-Harris, R. L., & Erritzøe, D. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01253-9 · Cited by 34 · see citing works
Self-citationZeifman, R. J., Kettner, H., Pagni, B. A., Mallard, A. J., Roberts, D. E., Erritzøe, D., Ross, S., & Carhart-Harris, R. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-40856-5 · Cited by 33 · see citing works
Self-citationTherapeutic uses of psychedelics for eating disorders and body dysmorphic disorder
Ledwos, N., Rodas, J. D., Husain, M. I., Feusner, J. D., & Castle, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140009 · Cited by 22 · see citing works
Hübner, S., Haijen, E. C. H. M., Kaelen, M., Carhart-Harris, R. L., & Kettner, H. (2021) · Journal of Medical Internet Research · doi:10.2196/25973 · Cited by 20 · see citing works
Self-citationKangaslampi, S. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05703-9 · Cited by 21 · see citing works
Beyond the death drive: Entropy and free energy
Rabeyron, T. (2021) · The International journal of psycho-analysis · doi:10.1080/00207578.2021.1932514 · Cited by 19 · see citing works
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability
Rossi, G. N., Dias, I. C. D. S., Baker, G. B., Bouso, J. C., Dursun, S. M., Hallak, J. E. C., & SANTOS, R. G. D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2054988 · Cited by 21 · see citing works
A Phenomenology of Challenging Psychedelic Experiences: From Relational Trauma to Relational Healing
Guthrie, L. (2021) · Cited by 19 · see citing works
Artru, E., & Rabeyron, T. (2021) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2021.03.013 · Cited by 17 · see citing works
Hearn, B. (2021) · The Journal of Humanistic Counseling · doi:10.1002/johc.12164 · Cited by 15 · see citing works
Suicidal Ideation and Obsessive-Compulsive Disorder: Links and Knowledge
Benster, L. L., Weissman, C. R., & Daskalakis, Z. J. (2022) · Psychology Research and Behavior Management · doi:10.2147/prbm.s368585 · Cited by 15 · see citing works
Kuburi, S., Passa, A.-M. D., Tassone, V. K., Mahmood, R., Lalovic, A., Ladha, K. S., Dunlop, K., Rizvi, S. J., Demchenko, I., & Bhat, V. (2022) · Chronic Stress · doi:10.1177/24705470221115342 · Cited by 13 · see citing works
Psychedelic therapy as reality transformation: A phenomenological approach
Petrement, M. S. (2023) · Journal of Psychedelic Studies · doi:10.1556/2054.2023.00231 · Cited by 12 · see citing works
Meshkat, S., Zeifman, R. J., Stewart, K. E., Janssen‐Aguilar, R., Lou, W. Y. W., Jetly, R., Monson, C. M., & Bhat, V. (2025) · PLoS ONE · doi:10.1371/journal.pone.0313741 · Cited by 12 · see citing works
Self-citationZeifman, R. J., Spriggs, M. J., Kettner, H., Lyons, T., Rosas, F. E., Mediano, P. A. M., Erritzøe, D., & Carhart-Harris, R. L. (2022) · doi:10.31234/osf.io/w8j6t · Cited by 12 · see citing works
Self-citationJohansen, L., Liknaitzky, P., Nedeljkovic, M., Mastin-Purcell, L., & Murray, G. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01930-7 · Cited by 11 · see citing works
“Through prospective surveys, Zeifman and colleagues [55] found experiential avoidance (the attempt to avoid or ignore negative or unwanted emotions or cognitions [56];) to be significantly reduced at 2 and 4 weeks after psychedelic use.”
BackgroundPsilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa
Rodan, S.-C., Aouad, P., McGregor, I. S., & Maguire, S. (2021) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2102102 · Cited by 11 · see citing works
Healy, C. J., Frazier, A., Kirsch, S., Sanford, A., Garcia‐Romeu, A., Todman, M., Varon, J. P., & D'Andrea, W. M. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111361 · Cited by 9 · see citing works
Psychedelic medicine: mechanisms, evidence, and translation to practice
Jacobs, E., Zahid, Z., Hinkle, J. T., Nayak, S. M., & Yaden, D. B. (2026) · BMJ · doi:10.1136/bmj-2024-081723 · Cited by 9 · see citing works
Bouso, J. C., Révész, D., Oña, G., Rossi, G. N., Rocha, J. M., SANTOS, R. G. D., Hallak, J. E. C., & Alcázar‐Córcoles, M. Á. (2023) · Scientific Reports · doi:10.1038/s41598-023-41199-x · Cited by 9 · see citing works
Zhang, Y., Yang, L., Zhang, Q., Li, C., Mao, F., & Zhuo, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03410-7 · Cited by 8 · see citing works
Psychedelics and psychological strengths
Brasher, T. J., Rosen, D., & Spinella, M. (2023) · International Journal of Wellbeing · doi:10.5502/ijw.v13i1.2325 · Cited by 8 · see citing works
A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history
Kramer, E. N., Reddy, K., & Shapiro, B. B. (2023) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2023.100118 · Cited by 8 · see citing works
Psychedelics and Suicide-Related Outcomes: A Systematic Review
Meshkat, S., Malik, T., Zeifman, R. J., Swainson, J., Zhang, Y., Burback, L., Winkler, O., Greenshaw, A. J., Reichelt, A. C., Vermetten, E. H. G. J. M., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051416 · Cited by 7 · see citing works
Self-citationRoseby, W., Kettner, H., Roseman, L., Spriggs, M. J., Lyons, T., Peill, J., Giribaldi, B., Erritzøe, D., Nutt, D. J., & Carhart-Harris, R. L. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1580663 · Cited by 7 · see citing works
Self-citationWahba, M., Hayes, C., Kletter, M., & McAllister-Williams, H. (2024) · BJPsych Open · doi:10.1192/bjo.2024.768 · Cited by 7 · see citing works
Irrmischer, M., Puxty, D. J., Yıldırım, B. O., Deijen, J. B., & Engelbregt, H. (2025) · Psychopharmacology · doi:10.1007/s00213-024-06733-3 · Cited by 6 · see citing works
Jones, J. L. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1565852 · Cited by 6 · see citing works
Gold, N. D., Mallard, A. J., Hermann, J. C., Zeifman, R. J., Pagni, B. A., Bogenschutz, M. P., & Ross, S. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2022.0604 · Cited by 6 · see citing works
Self-citationVilca-Melendez, S., Uthaug, M. V., & Griffin, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.742856 · Cited by 5 · see citing works
Rodan, S.-C., Meez, N., Lloyd-Hurwitz, S., Bedoya‐Pérez, M. A., Suraev, A. S., Sommer, N., Greenstien, K., Maguire, S., & McGregor, I. S. (2025) · Journal of Eating Disorders · doi:10.1186/s40337-025-01328-5 · Cited by 4 · see citing works
Bevione, F., Lacidogna, M. C., Lavalle, R., Daga, G. A., & Preti, A. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01771-y · Cited by 4 · see citing works
Exploring serotonergic psychedelics as a treatment for personality disorders
Carrithers, B. M., Roberts, D. E., Weiss, B., King, J. D., Carhart-Harris, R. L., Gordon, A. R., Pagni, B. A., Moreau, M., Ross, S., & Zeifman, R. J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110413 · Cited by 4 · see citing works
Self-citationExperiential Avoidance, Pain, and Suicide Risk in a National Sample of Gulf War Veterans
Grove, J. L., Young, J. R., Chen, Z., Blakey, S. M., Beckham, J. C., Calhoun, P. S., Dedert, E. A., Goldston, D. B., Pugh, M. J., & Kimbrel, N. A. (2022) · Archives of Suicide Research · doi:10.1080/13811118.2022.2160681 · Cited by 4 · see citing works
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Hu, X., Gorman, I., & Nielson, E. M. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_529 · Cited by 4 · see citing works
(Dis)connectedness, suicidality and group psychedelic therapies.Preprint
McAlpine, R. G., & Blackburne, G. (2024) · doi:10.31234/osf.io/haeqs · Cited by 3 · see citing works
Gordon, A. R., Carrithers, B. M., Pagni, B. A., Kettner, H., Marrocu, A., Nayak, S. M., Weiss, B. J., Carhart-Harris, R. L., Roberts, D. E., & Zeifman, R. J. (2024) · Research Square · doi:10.21203/rs.3.rs-4203641/v1 · Cited by 3 · see citing works
Self-citationAcupuncture for treating adolescent depression: Study protocol for a randomized controlled trial
Jiang, J., Liang, F., Xu, Z., Jin, W., Ji, B., & Li, L. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100273 · Cited by 2 · see citing works
Zeifman, R. J., Hernandez, K. M., Song, J., Liebman, R. E., Ip, J., Burdo, J., Johnson, C. M., Stirman, S. W., & Monson, C. M. (2024) · European Journal of Psychotraumatology · doi:10.1080/20008066.2024.2434315 · Cited by 2 · see citing works
Self-citationDahka, S. M., Ganjari, M. G., Sarparast, M., Kenarsari, H. E., Hassanpour, A., Morteza-Nejad, S. H. R. F., & Delpasand, K. (2021) · Journal of Guilan University of Medical Sciences · doi:10.32598/jgums.30.2.1700.1 · Cited by 2 · see citing works
Strika-Bruneau, L., Fauvel, B., Dupuis, D., & Benyamina, A. (2023) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2023.01.003 · Cited by 1 · see citing works
Saifullah, K., Zaffar, W., Qureshi, H. S., Ullah, R., & Laraib (2025) · Journal of Political Stability Archive · doi:10.63468/jpsa.3.3.23 · Cited by 1 · see citing works
Mehmood, M., Bremler, R., Spriggs, M. J., Kettner, H., Roseman, L., Damgaard, L., Carhart-Harris, R. L., Erritzøe, D., & Zeifman, R. J. (2025) · Psychedelic Medicine · doi:10.1177/28314425251392251 · Cited by 2 · see citing works
Self-citationRao, M., Dai, Q., Li, F., & Ye, B. (2026) · Journal of Adolescence · doi:10.1002/jad.70120 · Cited by 2 · see citing works
Erdmann, L., Breitenstein, B., Badanova, M., Telschow, L., Havenith, M. N., & Dziobek, I. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1777341 · Cited by 1 · see citing works
Baldour-Wang, M., Kotov, R., Gámez, W., Chmielewski, M. S., Ruggero, C. J., & Eaton, N. R. (2024) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-024-10159-8 · Cited by 2 · see citing works
Psychedelic-assisted grief therapy: a mixed-method case study
Sabucedo, P., Evans, C., Nicolson, D., Farré, M., & González, D. (2024) · Mortality · doi:10.1080/13576275.2024.2434456 · Cited by 2 · see citing works
Imany, M., Mohammadkhani, S., Atashipour, H. S., & Pourhosseini, P. (2025) · BMC Psychology · doi:10.1186/s40359-025-03364-x · Cited by 1 · see citing works
Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
Lutyens, D. (2023) · doi:10.26686/wgtn.21904854 · Cited by 1 · see citing works
Phenylketonuria with mental retardation and valproate-induced hyperammonemia
Sterpu, D. (2020) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2020.4.5
Breeksema, J. J. (2024) · doi:10.33612/diss.912040905
Zeifman, R. J. (2024) · doi:10.32920/26052859.v1 · Cited by 1 · see citing works
Self-citationAlshayea, A. K. (2024) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2024.100807
Integrating the Gestalt Model of Self With Psychedelic‐Assisted Psychotherapy
Fox, T. R. (2025) · The Journal of Humanistic Counseling · doi:10.1002/johc.70026
Gordon, A. R., Carrithers, B. M., Pagni, B. A., Kettner, H., MRes, A. M., Nayak, S. M., Weiss, B., Carhart-Harris, R. L., Roberts, D. E., Erritzøe, D., et al. (2025) · Psychedelic Medicine · doi:10.1177/28314425251382930
Self-citationPredictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review
Chmiel, J., & Rybakowski, F. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052202 · Cited by 1 · see citing works
Carhart-Harris, R. L., Zeifman, R. J., Pasquini, L., Nandi, B., Rohani-Shukla, C., Suseelan, S., Mediano, P. A. M., Rosas, F. C. W., Timmermann, C., Kettner, H., et al. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1875339
Self-citationEffectiveness of Acceptance and Commitment Therapy in Patients With Depression
Sarwar, I., Raza, M. A., & Majeed, A. (2026) · Counselling and Psychotherapy Research · doi:10.1002/capr.70157
Modlin, N. L., Elek, Z., Maggio, C., Agrawal, M., Lepow, L., Rucker, J., Stubley, J., & Guss, J. R. (2026) · Psychodynamic Psychiatry · doi:10.1521/pdps.2026.54.2.338
Clark, T. A. (2025) · The Therapeutic Conversation · doi:10.66330/100520252
Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK
Zinchenko, R. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10729
- Authors
- Zeifman, R. J., Wagner, A. C., Watts, R., Kettner, H., Mertens, L. J., & Carhart-Harris, R. L.
- Affiliations
- Imperial College London (GB)
- Heidelberg University (DE)
- Corresponding author
- Zeifman, Richard J.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2020-08-07
- Volume
- 11
- Pages
- 782-782
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC7438781
- OpenAlex
- W3047886920
- Cited by
- 106
- References
- 98
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 17 · 2023: 17 · 2022: 18 · 2021: 20 · 2020: 4
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Canadian Institutes of Health Research
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- psychedelics, experiential avoidance, depression severity, suicidal ideation, acceptance and commitment therapy, transdiagnostic mechanisms, psychedelic therapy, treatment outcomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review